Product Information
EMTRICITABINE 200 MG CAPSULE is a generic product labeled by Cipla USA Inc., priced at $12.2497 per EA under NDC 69097064202. Its NADAC has been published 115 times since Apr 17, 2024.
Strength
200 mg/1
Manufacturer
Cipla USA Inc.NDC
69097064202
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
EMTRICITABINEApproval Type
Generic (ANDA)
FDA Application
ANDA091168On Market Since
8/31/2020
Pharmacological Classes
Price Statistics
The NADAC for EMTRICITABINE 200 MG CAPSULE has been published 115 times since Apr 17, 2024, and over the history we have for it it has declined 16.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.2497 per EA |
|---|---|
| All-time high | $14.7020 (Aug 14, 2024) |
| All-time low | $12.2497 (Jun 17, 2026) |
| 52-week high | $14.5100 |
| 52-week low | $12.2497 |
| Median price | $14.1121 |
| Average price | $14.1378 |
| Largest weekly change | -14.4% (May 20, 2026) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the emtricitabine market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of EMTRICITABINE 200 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for EMTRICITABINE 200 MG CAPSULE, manufactured by Cipla USA Inc., is $12.2497 per EA (NDC 69097064202), effective Jun 24, 2026.
How has the price of EMTRICITABINE 200 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for EMTRICITABINE 200 MG CAPSULE has declined 16.7%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for EMTRICITABINE 200 MG CAPSULE?
Since Apr 17, 2024, the NADAC for EMTRICITABINE 200 MG CAPSULE has ranged from a low of $12.2497 (Jun 17, 2026) to a high of $14.7020 (Aug 14, 2024), with a median of $14.1121 per EA.
Are there cheaper alternatives to EMTRICITABINE 200 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of EMTRICITABINE 200 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures EMTRICITABINE 200 MG CAPSULE?
EMTRICITABINE 200 MG CAPSULE (NDC 69097064202) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification